Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis

NCT06680661 is registered in ClinicalTrials.gov with Leland Metheny as lead sponsor.

NCT NCT06680661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06680661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis
Lead sponsor
Leland Metheny
Phase
Phase 2
Overall status
Suspended
Start date
April 8, 2026
Completion date
October 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphatic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, chronic myelomonocytic leukemia, hodgkin lymphoma, lymphoma, myelodysplastic syndrome other, myelodysplastic syndromes